Key result
Supplementary protocol lists approving ethical bodies for valsartan and fluvastatin in the VF-HT-AF trial.
Answers are grounded in this paper and cite their sources.
Ethical bodies that approved the study.
No takes yet. Share an insight, caveat, or question.
Qi et al. (2015) studied this question. Valsartan and fluvastatin are the interventions in the VF-HT-AF trial, for which this supplementary protocol file lists the approving ethical bodies.
Synapse has enriched 10 related papers. Consider them for comparative context: